Skip to main navigation Skip to search Skip to main content

Continuous-Flow Syntheses of Active Pharmaceutical Ingredients

  • R. L. Beingessner
  • , A. R. Longstreet
  • , T. A. McTeague
  • , L. P. Kelly
  • , H. Seo
  • , T. H. Tran
  • , A. C. Wicker
  • , T. F. Jamison

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

This chapter describes synthetic strategies and technologies used to perform multistep flow syntheses of active pharmaceutical ingredients (APIs). The APIs or potential drug candidates highlighted are efavirenz, imatinib, (-)-oseltamivir, ibuprofen, rolipram, methylphenidate hydrochloride, and rufinamide.

Original languageEnglish
Title of host publicationScience of Synthesis
EditorsT.F. Jamison, G. Koch
PublisherGeorg Thieme Verlag
Pages429-462
Number of pages34
Edition5
ISBN (Electronic)9783132423350
ISBN (Print)9783132423312
DOIs
StatePublished - 2018

Publication series

NameScience of Synthesis
Number5
Volume2018
ISSN (Print)2510-5469
ISSN (Electronic)2566-7297

Keywords

  • biphasic synthesis
  • continuous-flow synthesis
  • copper tubing reactors
  • essential medicines
  • fully continuous
  • inline purification
  • inline separation
  • multistep processes
  • packed-bed reactors
  • polymer-supported catalysts
  • semi-continuous

Fingerprint

Dive into the research topics of 'Continuous-Flow Syntheses of Active Pharmaceutical Ingredients'. Together they form a unique fingerprint.

Cite this